independent.co.uk
July 22, 2013
British drug company GlaxoSmithKline is under investigation for claims its employees bribed doctors in China, as the president of its Asia-Pacific branch admitted executives “appear” to have broken the law.
Police say the company’s employees used travel agencies and consulting firms to hide a total of 3 billion yuan (£320 million), allowing them to evade GlaxoSmithKline’s internal anti-bribery controls. Investigators could not confirm how much of the funds had been paid to doctors.
The police ministry has said four employees of GSK’s China unit, including a vice president, have been detained. The company says its finance director for China was not among them, but has been barred from leaving the country.
The Emergency Election Sale is now live! Get 30% to 60% off our most popular products today!